As
filed with the Securities and Exchange Commission on September 25,
2020
Registration
No. 333-248505
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Amendment No. 1 to
FORM
S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
IT
Tech Packaging, Inc.
(Exact name of registrant as specified
in its charter)
Nevada |
|
20-4158835 |
(State
or other jurisdiction of
incorporation or organization) |
|
(I.R.S.
employer
identification number) |
Science
Park, Juli Rd, Xushui
District, Baoding City
Hebei Province, The People’s
Republic of China 072550
011 - (86) 312-8698215
(Address,
including zip code, and telephone number, including area code, of
registrant’s principal executive offices)
CSC
Services of Nevada, Inc.
2215-B Renaissance Dr.
Las Vegas, NV 89119
1-800-927-9801
(Name,
address, including zip code, and telephone number, including area
code, of agent for service)
Copies
to:
Mitchell S. Nussbaum, Esq.
Giovanni
Caruso, Esq.
Loeb & Loeb LLP
345 Park Ave
New York, New York 10154
(212) 407-4000
Approximate
date of commencement of proposed sale to the public: As soon as
practicable after the effective date of this registration
statement.
If
the only securities being registered on this Form are being offered
pursuant to dividend or interest reinvestment plans, please check
the following box: ☐
If
any of the securities being registered on this Form are to be
offered on a delayed or continuous basis pursuant to Rule 415 under
the Securities Act of 1933 check the following
box. ☒
If
this Form is filed to register additional securities for an
offering pursuant to Rule 462(b) under the Securities Act, please
check the following box and list the Securities Act registration
statement number of the earlier effective registration statement
for the same offering. ☐
If
this Form is a post-effective amendment filed pursuant to Rule
462(c) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier
effective registration statement for the same
offering. ☐
If
this Form is a registration statement pursuant to General
Instruction I.D. or a post-effective amendment thereto that shall
become effective upon filing with the Commission pursuant to Rule
462(e) under the Securities Act, check the following box.
☐
If
this Form is a post-effective amendment to a registration statement
filed pursuant to General Instruction I.D. filed to register
additional securities or additional classes of securities pursuant
to Rule 413(b) under the Securities Act, check the following
box. ☐
Indicate
by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of “large accelerated
filer,” “accelerated filer” and “smaller reporting company” in Rule
12b2 of the Exchange Act.
Large Accelerated Filer |
☐ |
|
Accelerated filer |
☐ |
Non-accelerated
filer |
☒ |
|
Smaller reporting company |
☒ |
|
|
|
Emerging
growth company |
☐ |
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 7(a)(2)(B) of Securities Act. ☐
CALCULATION
OF REGISTRATION FEE
Title of each Class of Security being Registered |
|
Amount
being
Registered(1) |
|
|
Proposed Maximum Offering Price Per Security |
|
|
Proposed Maximum Aggregate Offering Price |
|
|
Amount of Registration Fee |
|
Common
Stock, $0.001 par value per share (2) |
|
|
4,400,000 |
|
|
$ |
0.7425 |
(3) |
|
$ |
3,267,000 |
|
|
$ |
424.06 |
(4) |
|
(1) |
Pursuant
to Rule 416 of the Securities Act of 1933, as amended (the
“Securities Act”), the securities being registered
hereunder also include such presently indeterminate number of
shares of the registrant’s Common Stock as a result of stock
splits, stock dividends or similar transactions. |
|
(2) |
We
are registering for resale by the Selling Shareholders named herein
4,400,000 shares of common stock issuable upon the exercise of
certain warrants issued on May 4, 2020 to the Selling Shareholders,
each of whom is an accredited investor, in a private placement
pursuant to a Securities Purchase Agreement dated as of April 29,
2020, as amended on May 4, 2020, by and among the registrant and
the purchasers named therein. |
|
(3) |
Estimated
solely for the purpose of calculating the registration fee in
accordance with Rule 457(g) under the Securities Act and is based
on the exercise price of the warrants pursuant to which such shares
are issuable. |
The
Registrant hereby amends this Registration Statement on such date
or dates as may be necessary to delay its effective date until the
Registrant shall file a further amendment which specifically states
that this Registration Statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act of 1933, as
amended, or until the Registration Statement shall become effective
on such date as the Commission, acting pursuant to said Section
8(a), may determine.
The information in this prospectus is not complete and may be
changed. The selling stockholders may not sell these securities
publicly until the registration statement filed with the Securities
and Exchange Commission is effective. This prospectus is not an
offer to sell these securities and is not soliciting an offer to
buy these securities in any state where the offer or sale is not
permitted.
SUBJECT TO COMPLETION, SEPTEMBER 25, 2020

4,400,000
Shares of Common Stock
This
prospectus relates to the resale of up to 4,400,000 shares of
common stock, $0.001 par value, of IT Tech Packaging, Inc., a
Nevada corporation (the “Company”), that may be sold from time to
time by the selling stockholders named in this prospectus (the
“Selling Stockholders”).
The
shares of common stock offered under this prospectus consist of an
aggregate of 4,400,000 shares of common stock issuable upon the
exercise of outstanding warrants that were issued to the Selling
Shareholders in May 2020 in a private placement (the
“Warrants”).
We
will not receive any proceeds from the sale of any of the shares of
common stock by the Selling Stockholders.
Our
common stock is traded on the NYSE American under the symbol “ITP.”
On September 24, 2020, the closing price of our common stock on the
NYSE American was $0.4550.
Investing
in our securities involves a high degree of risk. You should
carefully consider the risk factors beginning on page 5 of this
prospectus before purchasing shares of our common
stock.
Neither
the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or
determined if this prospectus is truthful or complete. Any
representation to the contrary is a criminal
offense.
The
date of this prospectus is
,
2020
PROSPECTUS
SUMMARY
The
following summary, because it is a summary, may not contain all the
information that may be important to you. This prospectus
incorporates important business and financial information about our
company that is not included in, or delivered with this
prospectus. Before making an investment, you should read
the entire prospectus carefully. You should also carefully read the
risks of investing discussed under “Risk Factors” and the financial
statements included in our other filings with the Securities and
Exchange Commission, or SEC, including in our Annual Report on Form
10-K for the year ended December 31, 2019, which we filed with the
SEC on March 23, 2020, our Quarterly Report on Form 10-Q for the
quarter ended March 31, 2020, which we filed with the SEC on May
14, 2020, and our Quarterly Report on Form 10-Q for the quarter
ended June 30, 2020, which we filed with the SEC on August 11,
2020. This information is incorporated by reference into this
prospectus, and you can obtain it from the SEC as described below
under the headings “Where You Can Find Additional Information About
Us” and “Incorporation of Certain Documents by
Reference.”
We
will provide to each person, including any beneficial owner, to
whom a prospectus is delivered, a copy of any or all of the
information that has been incorporated by reference in the
prospectus but not delivered with the prospectus. You may request a
copy of these filings, excluding the exhibits to such filings which
we have not specifically incorporated by reference in such filings,
at no cost, by writing us at the following address: c/o IT Tech
Packaging, Inc., Science Park, Juli Rd, Xushui District, Baoding
City, Hebei Province, The People’s Republic of China 072550,
Attention: Secretary. For purposes of this prospectus, references
to the terms “IT Tech Packaging,” the “Company,” “we,” “us,” “ITP”
and “our” refer to IT Tech Packaging, Inc., collectively with its
subsidiaries, unless the context otherwise requires.
OUR
COMPANY
Overview
We
were incorporated in the State of Nevada in 2005. We engage in the
production and distribution of various categories of paper
products, such as corrugating medium paper, offset printing paper
and tissue paper products, and non-medical single-use face masks.
Our principal executive offices are located at Science Park, Juli
Road, Xushui District, Baoding City, Hebei Province, People’s
Republic of China 072550. Our telephone number is (86)
312-869-8215. Our website is located at
http://www.itpackaging.cn.
Our
Products
Corrugating
medium paper
Corrugating
medium paper, or CMP, is used in the manufacturing of cardboard.
Since the launch of our new Paper Machine (“PM6”) production line
in December 2011, corrugating medium paper has become a major
product of the Company. For the year ended December 31, 2019,
corrugating medium paper comprised approximately 85.61% of our
total paper production quantities and roughly 77.22% of our total
revenue. Raw materials used in the production of
corrugating medium paper include recycled paper board (or Old
Corrugating Cardboard or “OCC,” as it is commonly referred to in
the United States) and certain supplementary agents. In January
2013, we suspended the operation of our PM1 production line for
renovation, which was used at that time to produce corrugating
medium paper. In May 2014, we launched the commercial production
from a renovated PM1 production line. The renovated PM1 production
line produces light-weight corrugating medium paper with a
specification of 40 to 80 grams per square meter (“g/s/m”). PM1’s
light-weight corrugating medium paper products have a wide range of
commercial applications. For example, they can be used as a
construction material for wall and floor insulation or to
manufacture moisture-proof packaging materials for the
transportation of books and magazines by the publishing industry.
It can also be used as corrugating medium to make corrugating
cardboard for packaging that requires light-weight boxes. The
manufacturing process of light-weight corrugating medium paper is
similar to that of the regular corrugating medium paper and also
uses recycled paper boards as a major source of raw material. We
now have two corrugating medium paper production lines, PM6 and
PM1. We refer to products produced from the PM6 production line as
Regular CMP and products produced from the PM1 production line as
Light-Weight CMP.
Offset
printing paper
Offset
printing paper is used for offset printing in the publishing
industry. Offset printing paper comprised approximately
11.68% of our total paper production quantities and approximately
17.38% of our total sales revenue for the year ended December 31,
2019. Raw materials used in making offset printing paper
include recycled white scrap paper, fluorescent whitening
agent and sizing agent. We currently have two production lines, PM2
and PM3, for the production of offset printing paper.
Tissue
paper products
We
began the commercial production of tissue paper products in Wei
County Industry Park in June 2015. We process base tissue paper
purchased from a long-term cooperative third party and produce
finished tissue paper products, including toilet paper, boxed and
soft-packed tissues, handkerchief tissues and paper napkins, as
well as bathroom and kitchen paper towels that are marketed and
sold under the Dongfang Paper brand. In December 2018 and November
2019, we completed the construction, installation and test of
operation of PM8 and PM9, respectively, and commercially launched
tissue paper production of PM8 and PM9 at such time. Tissue paper
products comprised approximately 2.71% of our total paper
production quantities and approximately 5.4% of our total sales
revenue for the year ended December 31, 2019.
Our
Customers and Market
We
generally sell our products to companies making corrugated
cardboards (in the case of our packaging products like corrugating
medium paper) and to printing companies (in the case of our
printing paper products). Our primary market has been the region of
North China, specifically in the province of Hebei. We target
corporate customers in the middle range of the marketplace, where
products such as corrugating medium paper and mid-grade offset
printing paper with reasonable quality and competitive pricing have
potential for high volume growth.
Our
Raw Materials and Principal Suppliers
The
supplies used in our production processes are comprised mainly of
recycled paper board and unprinted recycled white scrap paper, both
of which are ready-to-use items and available from multiple
domestic and foreign sources. We currently purchase all of our
recycled paper supplies from domestic recycling stations and do not
rely on imported recycled paper. We also purchase coal, natural gas
and chemical agents from nearby suppliers. Ongoing inflationary
pressures and higher demand for recycled paper could lead to an
increase in our costs of raw materials and production, which we may
or may not be able to pass to our customers. We sign annual raw
materials supplier contracts with our suppliers. Although we have
contracts with our suppliers, these contracts do not lock-in the
purchase price of our raw materials or provide a hedge against the
fluctuation in the market price of these raw materials.
Competition
Our
main competitors are: Chenming Paper Group Limited (“Chenming”),
Huatai Group Limited, Nine Dragons Paper (Holdings) Limited (“ND
Paper”) and Sun Paper Group Limited. A number of our
competitors are public entities with larger capacity, broader
customer bases and greater financial resources than those available
to us. With the exceptions of Chenming and ND Paper, which may
compete directly with us in the offset printing paper market and
the corrugating medium paper market, respectively, in the
Beijing/Tianjin/greater Hebei regions, we believe that we face only
indirect competition from the aforesaid companies, either because
we have a different product assortment from these companies, or
because, to the extent they do offer products similar to ours, the
transportation costs and storage costs make it difficult for these
companies to compete effectively with us on pricing.
Employees
As of
December 31, 2019, we had approximately 428 full time employees.
These employees are organized into a labor union under the labor
laws of the PRC and have collective bargain power against
us. We generally maintain good relations with our
employees and the labor union.
Recent
Developments
Face
Masks Production
On
April 29, 2020, we launched a production line of non-medical
single-use face masks, following the completion of raw materials
preparation, trial run of the equipment and the sample products
inspection. Revenue generated from selling face masks were $845,553
for the three and six months ended June 30, 2020. We sold 6.28
million pieces of face masks in the second quarter and the six
months ended June 30, 2020.
Registered
Direct Offering and Concurrent Private Placement
On
May 4, 2020, we consummated a registered direct offering of
4,400,000 shares of our common stock (the “Shares”) to certain
accredited institutional investors and a concurrent private
placement of warrants to purchase 4,400,000 shares of common stock
(the “Warrants”). The Warrants are exercisable beginning on or
after the earlier of (i) November 4, 2020, and (ii) the date we
receive stockholder approval at an exercise price of $7.53 per
share, and will expire on November 4, 2025 (the date that is five
years and six months after the date of issuance). On July 23, 2020,
we received the stockholder approval for the reduction of the
exercise price of the Warrants from $7.53 to $0.7425.
The
combined purchase price for one Share and one Warrant in the
offering was $0.58. We received aggregate gross proceeds of
approximately $2.55 million in the offering, before deducting fees
to the placement agents and other offering expenses.
The
Shares were offered by the Company pursuant to an effective shelf
registration statement on Form S-3 (File No. 333-223160), which was
declared effective on June 19, 2018. The Warrants and the shares of
common stock issuable upon exercise of the Warrants were issued in
a concurrent private placement and have not been registered under
the Securities Act of 1933, as amended (the “Securities Act”), and
were offered pursuant to the exemption provided in Section 4(a)(2)
under the Securities Act and Rule 506(b) promulgated thereunder.
Maxim Group LLC, acted as our exclusive placement agent for the
offering.
New
Tissue Paper Production Line (“PM10”)
On
May 5, 2020, the Company announced it planned the commercial launch
of a new tissue paper production line (the "PM10"). The Company has
signed an agreement to purchase paper machine with paper machine
supplier and expects to launch commercial production of the PM10
following the success of its trial run.
Combined
Heat and Power Generation Project
On
June 24, 2020, the Company announced that it expected to launch the
construction of a combined heat and power generation project
utilizing biomass technology with the total construction area of
80,373 square meters which is located in its Wei County production
base.
The
Offering
Shares
of Common Stock outstanding |
|
Approximately
28,514,816 shares (as of September 25, 2020) |
|
|
|
Shares
of Common Stock offered by the Selling Stockholders |
|
Up to
4,400,000 shares |
|
|
|
Shares
of Common Stock to be outstanding immediately after the offering,
assuming full exercise for cash of the Warrants |
|
Approximately
32,914,816 shares(1) |
|
|
|
Use
of Proceeds |
|
We
will not receive any of the proceeds from the sale of the shares by
the Selling Stockholders. See “Use of Proceeds” on page 5 of this
prospectus. However, if all of the Warrants are exercised for cash,
we would receive an aggregate of $3,267,000. |
|
|
|
Transfer
Agent and Registrar |
|
Empire
Stock Transfer Inc.. |
|
|
|
Risk
Factors |
|
Investment
in our securities involves a high degree of risk. See Risk Factors”
on page 5 of this prospectus and under similar sections in the
documents we incorporate by reference into this prospectus for a
discussion of factors you should consider carefully before making
an investment decision. |
|
|
|
NYSE
American Symbol |
|
“ITP” |
|
(1) |
The
number of shares of common stock to be outstanding after this
offering is based on 28,514,816 shares of common stock outstanding
as of September 25, 2020. |
RISK
FACTORS
Investing
in our securities involves risk. Before making an investment
decision, you should carefully consider the risks described under
“Item 1A. Risk Factors” in our most recent Annual Report on Form
10-K, and any updates to our risk factors in our Quarterly Reports
on Form 10-Q, together with all of the other information appearing
in or incorporated by reference into this prospectus, in light of
your particular investment objectives and financial circumstances.
Our business, financial condition or results of operations could be
materially adversely affected by any of these risks. The trading
price of our securities could decline due to any of these risks,
and you may lose all or part of your investment.
FORWARD-LOOKING
STATEMENTS
This
prospectus, including the documents we have filed with the SEC that
are incorporated herein by reference, contains forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended (the “Securities Act”) and Section 21E of the
Exchange Act. Forward-looking statements deal with our current
plans, intentions, beliefs and expectations and statements of
future economic performance. Statements containing terms such as
“believe,” “do not believe,” “plan,” “expect,” “intend,”
“estimate,” “anticipate” and other phrases of similar meaning are
considered to contain uncertainty and are forward-looking
statements. In addition, from time to time we or our
representatives have made or will make forward-looking statements
orally or in writing. Furthermore, such forward-looking statements
may be included in various filings that we make with the SEC, or
press releases or oral statements made by or with the approval of
one of our authorized executive officers. These forward-looking
statements are subject to certain known and unknown risks and
uncertainties, as well as assumptions that could cause actual
results to differ materially from those reflected in these
forward-looking statements. Factors that might cause actual results
to differ include, but are not limited to, those set forth under
“Risk Factors” incorporated by reference in this prospectus and
those discussed in Item 7, “Management’s Discussion and Analysis of
Financial Condition and Results of Operation,” in our Annual Report
on Form 10-K for the fiscal year ended December 31, 2019 and in our
future filings made with the SEC. Readers are cautioned not to
place undue reliance on any forward-looking statements contained in
this prospectus or the documents we have filed with the SEC that
are incorporated herein by reference, which reflect management’s
opinions only as of their respective dates. Except as required by
law, we undertake no obligation to revise or publicly release the
results of any revisions to any forward-looking statements. You are
advised, however, to consult any additional disclosures we have
made or will make in our reports to the SEC on Forms 10-K, 10-Q and
8-K. All subsequent written and oral forward-looking statements
attributable to us or persons acting on our behalf are expressly
qualified in their entirety by the cautionary statements contained
or incorporated by reference in this prospectus, any prospectus
supplement or any related issuer free writing
prospectus.
USE OF
PROCEEDS
We
will not receive any proceeds from the sale of shares of common
stock by the Selling Stockholders. However, if the holders of
Warrants exercise their Warrants for cash, we would receive an
aggregate of $3,267,000 upon such exercise.
DESCRIPTION OF
SECURITIES
General
The
following summary description sets forth some of the general terms
and provisions of our common stock. Because this is a summary
description, it does not contain all of the information that may be
important to you. For a more detailed description of our common
stock, you should refer to the applicable provisions of the Nevada
Revised Statutes and our charter and bylaws as in effect at the
time of any offering. Copies of our articles of incorporation, as
amended, and our bylaws are included as exhibits to the
registration statement of which this prospectus forms a
part.
As of
September 25, 2020, our authorized capital stock consists of
500,000,000 shares of common stock, $0.001 par value per share, of
which 28,514,816 shares are issued and outstanding.
The
authorized and unissued shares of our common stock are available
for issuance without further action by our stockholders, unless
such action is required by applicable law or the rules of the NYSE
American, or any stock exchange on which our securities may be
listed at such time. Unless approval of our stockholders is so
required, our board of directors will not seek stockholder approval
for the issuance and sale of our common stock.
Common
Stock
Each
outstanding share of our common stock is entitled to one vote,
either in person or by proxy, on all matters that may be voted upon
by their holders at meetings of the stockholders.
Holders
of our common stock:
|
(i) |
have
equal ratable rights to dividends from funds legally available
therefore, if declared by the Board of Directors; |
|
(ii) |
are
entitled to share ratably in all our assets available for
distribution to holders of common stock upon our liquidation,
dissolution or winding up; |
|
(iii) |
do
not have preemptive, subscription or conversion rights;
and |
|
(iv) |
are
entitled to one non-cumulative vote per share on all matters on
which stockholders may vote at all meetings of our
stockholders. |
The
holders of shares of our common stock do not have cumulative voting
rights, which means that the holder or holders of more than fifty
percent (50%) of outstanding shares voting for the election of
directors can elect all of our directors if they so choose and, in
such event, the holders of the remaining shares will not be able to
elect any of the our directors.
Our
common stock is listed on The NYSE American under the symbol
“ITP.”
Anti-takeover
Effects of Nevada Law and our Articles of Incorporation, as amended
and Bylaws
See
“Certain Provisions of Nevada Law and of the Company’s Articles of
Incorporation, as amended and Bylaws” for a description of
provisions of our articles of incorporation, as amended and Bylaws,
which may have the effect of delaying changes in our control or
management..
Transfer
Agent and Registrar
The
transfer agent and registrar for our common stock is Empire Stock
Transfer Inc.
CERTAIN
PROVISIONS OF NEVADA LAW AND OF OUR ARTICLES OF
INCORPORATION, AS AMENDED AND BYLAWS,
Our
articles of incorporation and bylaws contain a number of provisions
that could make our acquisition by means of a tender or exchange
offer, a proxy contest or otherwise more difficult. Certain of
these provisions are summarized below.
Special
Meetings.
Special
meetings of the stockholders may only be called by our board of
directors or such person or person authorized by the board of
directors.
Control
Share Acquisitions
The
“control share” provisions of Sections 78.378 to 78.3793,
inclusive, of the NRS, apply to “issuing corporations” that are
Nevada corporations with at least 200 stockholders of record,
including at least 100 stockholders of record who are Nevada
residents, and that conduct business directly or indirectly in
Nevada, unless the corporation has elected to not be subject to
these provisions. The control share statute prohibits an acquirer
of shares of an issuing corporation, under certain circumstances,
from voting its shares of a corporation’s stock after crossing
certain ownership threshold percentages, unless the acquirer
obtains approval of the target corporation’s disinterested
stockholders. The statute specifies three thresholds: (a) one-fifth
or more but less than one-third, (b) one-third but less than a
majority, and (c) a majority or more, of the outstanding voting
power. Generally, once a person acquires shares in excess of any of
the thresholds, those shares and any additional shares acquired
within 90 days thereof become “control shares” and such control
shares are deprived of the right to vote until disinterested
stockholders restore the right. These provisions also provide that
if control shares are accorded full voting rights and the acquiring
person has acquired a majority or more of all voting power, all
other stockholders who do not vote in favor of authorizing voting
rights to the control shares are entitled to demand payment for the
fair value of their shares in accordance with statutory procedures
established for dissenters’ rights. A corporation may elect to not
be governed by, or “opt out” of, the control share provisions by
making an election in its articles of incorporation or bylaws,
provided that the opt-out election must be in place on the 10th day
following the date an acquiring person has acquired a controlling
interest, that is, crossing any of the three thresholds described
above. We have not opted out of these provisions and will be
subject to the control share provisions of the NRS if we meet the
definition of an issuing corporation upon an acquiring person
acquiring a controlling interest unless we later opt out of these
provisions and the opt out is in effect on the 10th day following
such occurrence.
The
effect of the Nevada control share statute is that the acquiring
person, and those acting in association with the acquiring person,
will obtain only such voting rights in the control shares as are
conferred by a resolution of the stockholders at an annual or
special meeting. The Nevada control share law, if applicable, could
have the effect of discouraging takeovers of our
company.
SELLING
STOCKHOLDERS
We
are registering for resale an aggregate of 4,400,000 shares of our
common stock (the “Shares”) by the Selling Stockholders. The Shares
being offered by the Selling Stockholders are the 4,400,000 shares
issuable upon the exercise of the Warrants. We are registering the
Shares in accordance with the terms of the Securities Purchase
Agreement dated as of April 29, 2020, as amended on May 4, 2020,
among our Company and the investors in order to permit the Selling
Stockholders and their pledgees, donees, transferees and other
successors-in-interest that receive Shares from a Selling
Stockholder as a gift, partnership distribution or other non-sale
related transfer after the date of this prospectus to resell the
Shares when and as they deem appropriate in the manner described in
the “Plan of Distribution” to offer the Shares for resale from time
to time.
The
Selling Stockholder table below sets forth:
|
● |
the
name of the Selling Stockholders, |
|
● |
the
number and percentage of shares of our common stock that the
Selling Stockholders owned as of the date of this prospectus prior
to the offering for resale of the Shares under this
prospectus, |
|
● |
the
maximum number of shares of our common stock that may be offered
for resale for the account of the Selling Stockholders under this
prospectus, and |
|
● |
the
number and percentage of shares of our common stock to be owned by
the Selling Stockholders after the offering of the Shares (assuming
all of the offered Shares are sold by the Selling
Stockholders). |
None
of the Selling Stockholders has been an officer or director of the
Company or any of its predecessors or affiliates within the last
three years or otherwise had a material relationship with us within
the last three years. None of the Selling Shareholders is a
broker-dealer or an affiliate of a broker-dealer, who should be
identified as an underwriter. The total number of shares of common
stock sold under this prospectus may be adjusted to reflect
adjustments due to stock dividends, stock distributions, splits,
combinations or recapitalizations with regard to the common
stock.
Each
Selling Stockholder may sell all, some or none of its shares in
this offering. See “Plan of Distribution.”
Name of Selling Stockholder |
|
Number of Shares of Common Stock Beneficially Owned Prior to
Offering |
|
|
Maximum Number of Shares of Common Stock to be Sold Pursuant to
this Prospectus |
|
|
Number of Shares of Common Stock Beneficially Owned After
Offering |
|
|
Percentage of Shares of Common Stock Beneficially Owned After
Offering (1) |
|
Anson Investments Master
Fund LP (2) |
|
|
880,000 |
|
|
|
880,000 |
|
|
|
0 |
|
|
|
0.0 |
% |
CVI Investments, Inc. (3) |
|
|
880,000 |
|
|
|
880,000 |
|
|
|
0 |
|
|
|
0.0 |
% |
Hudson Bay Master Fund Ltd
(4) |
|
|
880,000 |
|
|
|
880,000 |
|
|
|
0 |
|
|
|
0.0 |
% |
Intracoastal Capital LLC (5) |
|
|
880,000 |
|
|
|
880,000 |
|
|
|
0 |
|
|
|
0.0 |
% |
L1 Capital Global Opportunities Master
Fund (6) |
|
|
880,000 |
|
|
|
880,000 |
|
|
|
0 |
|
|
|
0.0 |
% |
|
(1) |
The
total number of shares outstanding after the offering is based on
(i) 28,514,816 shares of common stock issued and outstanding as of
September 25, 2020, (ii) the issuance upon exercise of the
applicable warrants of all 4,400,000 common shares being offered by
this prospectus and (iii) for each shareholder and for that
shareholder only, the common shares underlying any options,
warrants or other convertible securities that may be acquired
within the next 60 days without giving regard to any limitation on
beneficial ownership applicable to such security. Such
total number of shares outstanding after the offering assumes we
issue no other common shares (including upon the exercise of
outstanding warrants, options or other convertible securities)
prior to the completion of this offering. |
|
(2) |
Anson
Advisors Inc and Anson Funds Management LP, the Co-Investment
Advisers of Anson Investments Master Fund LP (“Anson”), hold voting
and dispositive power over the Common Shares held by Anson. Bruce
Winson is the managing member of Anson Management GP LLC, which is
the general partner of Anson Funds Management LP. Moez Kassam and
Amin Nathoo are directors of Anson Advisors Inc. Mr. Winson, Mr.
Kassam and Mr. Nathoo each disclaim beneficial ownership of these
Common Shares except to the extent of their pecuniary interest
therein. The principal business address of Anson is Walkers
Corporate Limited, Cayman Corporate Centre, 27 Hospital Road,
George Town, Grand Cayman KY1-9008, Cayman Islands. The address for
notice to Anson is c/o Anson Advisor Inc., 155 University Ave.,
Suite 207, Toronto, ON CANADA M5H 3B7. |
|
(3) |
Heights
Capital Management, Inc., the authorized agent of CVI Investments,
Inc. (“CVI”), has discretionary authority to vote and dispose of
the shares held by CVI and may be deemed to be the beneficial owner
of these shares. Martin Kobinger, in his capacity as Investment
Manager of Heights Capital Management, Inc., may also be deemed to
have investment discretion and voting power over the shares held by
CVI. Mr. Kobinger disclaims any such beneficial ownership of the
shares. CVI Investments, Inc. is affiliated with one or more FINRA
member, none of whom are currently expected to participate in the
sale pursuant to the prospectus contained in the Registration
Statement of the shares in this offering. The address for notice of
CVI is c/o Heights Capital Management, Inc., 101 California Street,
Suite 3250, San Francisco, CA 94111. |
|
(4) |
Hudson
Bay Capital Management LP, the investment manager of Hudson Bay
Master Fund Ltd., has voting and investment power over these
securities. Sander Gerber is the managing member of Hudson Bay
Capital GP LLC, which is the general partner of Hudson Bay Capital
Management LP. Each of Hudson Bay Master Fund Ltd. and Sander
Gerber disclaims beneficial ownership over these securities. The
address for notices of Hudson Bay Master Fund Ltd. is c/o Hudson
Bay Capital Management LP, 777 Third Avenue, 30th Floor, New York,
New York. |
|
(5) |
Mitchell
P. Kopin (“Mr. Kopin”) and Daniel B. Asher (“Mr. Asher”), each of
whom are managers of Intracoastal Capital LLC (“Intracoastal”),
have shared voting control and investment discretion over the
shares held by Intracoastal. As a result, each of Mr. Kopin and Mr.
Asher may be deemed to have beneficial ownership of the shares held
by Intracoastal. The registered address of Intracoastal is 245 Palm
Trail, Delray Beach, FL 33483. The address for notice of
Intracoastal is 2211A Lakeside Drive, Bannockbum, IL
60015. |
|
(6) |
David
Feldman and Joel Arber are the Directors and have voting and
dispositive power over the securities owned by L1 Capital Global
Opportunities Master Fund (“L1 Capital”). The registered address of
L1 Capital is 161A Shedden Road, 1 Artillery Court, PO Box 10085,
Grand Cayman KY1-1001, Cayman Islands. |
PLAN OF
DISTRIBUTION
Each
Selling Stockholder of the securities and any of their pledgees,
assignees and successors-in-interest may, from time to time, sell
any or all of their securities covered hereby on the principal
trading market or any other stock exchange, market or trading
facility on which the securities are traded or in private
transactions. These sales may be at fixed or negotiated prices. A
Selling Stockholder may use any one or more of the following
methods when selling securities:
|
● |
ordinary
brokerage transactions and transactions in which the broker-dealer
solicits purchasers; |
|
● |
block
trades in which the broker-dealer will attempt to sell the
securities as agent but may position and resell a portion of the
block as principal to facilitate the transaction; |
|
● |
purchases
by a broker-dealer as principal and resale by the broker-dealer for
its account; |
|
● |
an
exchange distribution in accordance with the rules of the
applicable exchange; |
|
● |
privately
negotiated transactions; |
|
● |
settlement
of short sales entered into after the effective date of the
registration statement of which this prospectus is a
part; |
|
● |
in
transactions through broker-dealers that agree with the Selling
Stockholders to sell a specified number of such securities at a
stipulated price per security; |
|
● |
through
the writing or settlement of options or other hedging transactions,
whether through an options exchange or otherwise; |
|
● |
a
combination of any such methods of sale; or |
|
● |
any
other method permitted pursuant to applicable law. |
The
Selling Stockholders may also sell securities under Rule 144 under
the Securities Act, if available, rather than under this
prospectus.
Broker-dealers
engaged by the Selling Stockholders may arrange for other
brokers-dealers to participate in sales. Broker-dealers may receive
commissions or discounts from the Selling Stockholders (or, if any
broker-dealer acts as agent for the purchaser of securities, from
the purchaser) in amounts to be negotiated, but, except as set
forth in a supplement to this Prospectus, in the case of an agency
transaction not in excess of a customary brokerage commission in
compliance with FINRA Rule 2440; and in the case of a principal
transaction a markup or markdown in compliance with FINRA
IM-2440.
In
connection with the sale of the securities or interests therein,
the Selling Stockholders may enter into hedging transactions with
broker-dealers or other financial institutions, which may in turn
engage in short sales of the securities in the course of hedging
the positions they assume. The Selling Stockholders may also sell
securities short and deliver these securities to close out their
short positions, or loan or pledge the securities to broker-dealers
that in turn may sell these securities. The Selling Stockholders
may also enter into option or other transactions with
broker-dealers or other financial institutions or create one or
more derivative securities which require the delivery to such
broker-dealer or other financial institution of securities offered
by this prospectus, which securities such broker-dealer or other
financial institution may resell pursuant to this prospectus (as
supplemented or amended to reflect such transaction).
The
Selling Stockholders and any broker-dealers or agents that are
involved in selling the securities may be deemed to be
“underwriters” within the meaning of the Securities Act in
connection with such sales. In such event, any commissions received
by such broker-dealers or agents and any profit on the resale of
the securities purchased by them may be deemed to be underwriting
commissions or discounts under the Securities Act. Each Selling
Stockholder has informed us that it does not have any written or
oral agreement or understanding, directly or indirectly, with any
person to distribute the securities.
We
are required to pay certain fees and expenses incurred by us
incident to the registration of the securities. We have agreed to
indemnify the Selling Stockholders against certain losses, claims,
damages and liabilities, including liabilities under the Securities
Act.
Because
Selling Stockholders may be deemed to be “underwriters” within the
meaning of the Securities Act, they will be subject to the
prospectus delivery requirements of the Securities Act including
Rule 172 thereunder. In addition, any securities covered by this
prospectus which qualify for sale pursuant to Rule 144 under the
Securities Act may be sold under Rule 144 rather than under this
prospectus. The Selling Stockholders have advised us that there is
no underwriter or coordinating broker acting in connection with the
proposed sale of the resale securities by the Selling
Stockholders.
We
agreed to keep this prospectus effective until the earlier of (i)
the date on which the securities may be resold by the Selling
Stockholders without registration and without regard to any volume
or manner-of-sale limitations by reason of Rule 144, without the
requirement for us to be in compliance with the current public
information under Rule 144 under the Securities Act or any other
rule of similar effect or (ii) all of the securities have been sold
pursuant to this prospectus or Rule 144 under the Securities Act or
any other rule of similar effect. The resale securities will be
sold only through registered or licensed brokers or dealers if
required under applicable state securities laws. In addition, in
certain states, the resale securities covered hereby may not be
sold unless they have been registered or qualified for sale in the
applicable state or an exemption from the registration or
qualification requirement is available and is complied
with.
Under
applicable rules and regulations under the Exchange Act, any person
engaged in the distribution of the resale securities may not
simultaneously engage in market making activities with respect to
the common stock for the applicable restricted period, as defined
in Regulation M, prior to the commencement of the distribution. In
addition, the Selling Stockholders will be subject to applicable
provisions of the Exchange Act and the rules and regulations
thereunder, including Regulation M, which may limit the timing of
purchases and sales of securities of the common stock by the
Selling Stockholders or any other person. We will make copies of
this prospectus available to the Selling Stockholders and have
informed them of the need to deliver a copy of this prospectus to
each purchaser at or prior to the time of the sale (including by
compliance with Rule 172 under the Securities Act).
LEGAL
MATTERS
The
validity of the Shares of our common stock offered hereby has been
passed upon for us by Loeb & Loeb LLP, New York, New
York.
EXPERTS
The
consolidated financial statements and the related financial
statement schedule, incorporated in this prospectus by reference to
the Annual Report on Form 10-K for the year ended December 31,
2019, have been audited by WWC, P.C. Certified Public Accountants,
an independent registered public accounting firm, as stated in
their report incorporated by reference herein, and have been so
incorporated in reliance upon such report and upon the authority of
such firm as experts in accounting and auditing.
WHERE YOU CAN FIND
ADDITIONAL INFORMATION ABOUT US
We
have filed a registration statement on Form S-3 with the SEC for
the shares of our common stock we are offering by this prospectus.
This prospectus does not include all of the information contained
in the registration statement. You should refer to the registration
statement and its exhibits for additional information. We will
provide to each person, including any beneficial owner, to whom a
prospectus is delivered, a copy of any or all of the information
that has been incorporated by reference in the prospectus but not
delivered with the prospectus. We will provide this information
upon oral or written request, free of charge. Any requests for this
information should be made by calling or sending a letter to the
Secretary of the Company, c/o IT Tech Packaging, Inc., Science
Park, Juli Rd, Xushui District, Baoding City, Hebei Province, The
People’s Republic of China 072550. Our telephone number is (86)
312-8698215.
We
are required to file annual and quarterly reports, current reports,
proxy statements, and other information with the SEC. We make these
documents publicly available, free of charge, on our website at
www. itpackaging.cn as soon as reasonably practicable after filing
such documents with the SEC. You can read our SEC filings,
including the registration statement, on the SEC’s website at
www.sec.gov.
INCORPORATION OF
CERTAIN DOCUMENTS BY REFERENCE
The
following documents filed by us with the SEC are incorporated by
reference in this prospectus:
|
● |
Annual
Report on
Form 10-K for the fiscal year ended December 31, 2019, filed
with the SEC on March 23, 2020; |
|
● |
The
Company’s definitive proxy statement on
Schedule 14A, filed with the SEC on June 10, 2020; |
|
● |
Quarterly
Report on
Form 10-Q for the quarter ended March 31, 2020, filed with the
SEC on May 14, 2020; |
|
● |
Quarterly
Report on
Form 10-Q for the quarter ended June 30, 2020, filed with the
SEC on August 11, 2020; |
|
● |
The
description of our common stock set forth in our Registration
Statement on
Form 8-A filed with the Commission on May 10, 2007 (File No.
000-52639), including any amendments or reports filed for the
purpose of updating such description. |
We
also incorporate by reference all documents we file under Sections
13(a), 13(c), 14 or 15(d) of the Exchange Act (a) after the initial
filing date of the registration statement of which this prospectus
is a part and before the effectiveness of the registration
statement and (b) after the effectiveness of the registration
statement and before the filing of a post-effective amendment that
indicates that the securities offered by this prospectus have been
sold or that deregisters the securities covered by this prospectus
then remaining unsold. Any statement contained herein or in a
document incorporated or deemed to be incorporated by reference
herein shall be deemed to be modified or superseded for purposes
hereof to the extent that a statement in any other
subsequently filed document which is also incorporated or deemed to
be incorporated herein modifies or supersedes such statement. Any
such statement so modified or superseded shall not be deemed,
except as so modified or superseded, to constitute a part of this
prospectus.
You
should rely only on the information contained in this prospectus.
We have not authorized anyone to provide you with different or
additional information. If such information is provided to you, you
should not rely on it. This prospectus is not an offer of these
securities in any jurisdiction where an offer and sale is not
permitted.
IT
Tech Packaging, Inc.

4,400,000
Shares of Common Stock
PROSPECTUS
,
2020
PART
II
INFORMATION
NOT REQUIRED IN PROSPECTUS
Item
14. Other Expenses of Issuance and Distribution.
The
following table sets forth the various expenses, all of which will
be borne by the registrant, in connection with the sale and
distribution of the securities being registered, other than the
underwriting discounts and commissions. All amounts shown are
estimates except for the SEC registration fee.
SEC registration fee |
|
$ |
424.06 |
|
Accounting fees and expenses |
|
$ |
5,000.00 |
|
Legal
fees and expenses |
|
$ |
20,000.00 |
|
Miscellaneous |
|
$ |
1,000.00 |
|
Item
15. Indemnification of Officers and Directors.
Under
Sections 78.7502 and 78.751 of the Nevada Revised Statutes, the
Company has broad powers to indemnify and insure its directors and
officers against liabilities they may incur in their capacities as
such. The Company’s amended and restated articles of incorporation
implement the indemnification and insurance provisions permitted by
Chapter 78 of the Nevada Revised Statutes by providing
that:
|
● |
The
Company shall indemnify all its directors and officers to the
fullest extent permitted by Chapter 78 of the Nevada Revised
Statutes or any other law then in effect or as it may hereafter be
amended. The Company shall indemnify each of its present and future
directors and officers who becomes a party or is threatened to be
made a party to any suit or proceeding, against expenses,
including, but not limited to, attorneys’ fees, judgments, fines,
and amounts paid in settlement actually and reasonably incurred by
him in connection with the action, suit, proceeding or settlement,
provided such person acted in good faith and in a manner which he
reasonably believed to be in or not opposed to the best interest of
the Company, and, with respect to any criminal action or
proceeding, had no reasonable cause to believe his conduct was
unlawful. |
|
● |
The
expenses of directors and officers incurred in defending a civil or
criminal action, suit, or proceeding may be paid by the Company as
they are incurred and in advance of the final disposition of the
foregoing actions, if such person undertakes to repay said expenses
if it is ultimately determined by a court that he is not entitled
to be indemnified by the Company, meaning, a final adjudication
establishes that the person’s acts or omissions involved a breach
of any fiduciary duties, where applicable, intentional misconduct,
fraud or a knowing violation of the law which was material to the
cause of action. |
These
indemnification provisions may be sufficiently broad to permit
indemnification of the Company’s directors and officers for
liabilities (including reimbursement of expenses incurred) arising
under the Securities Act.
Insofar
as indemnification for liabilities arising under the Securities Act
may be permitted to our directors, officers or controlling persons
pursuant to the foregoing provisions, we have been informed that,
in the opinion of the SEC, such indemnification is against public
policy as expressed in the Securities Act and is therefore
unenforceable.
See
also the undertakings set out in response to
Item 17.
Item
16. Exhibits.
Exhibit
Number |
|
Description |
|
|
|
2.1 |
|
Agreement
and Plan of Merger, dated October 29, 2007, by and among
Carlateral, Inc., CARZ Merger Sub, Inc., Dongfang Zhiye Holding
Limited, and the shareholders of Dongfang Zhiye Holding Limited.
Incorporated by reference to Exhibit 10.1 to the Company’s Current
Report on Form 8-K filed with the SEC on November 2,
2007. |
3.1 |
|
Articles
of Incorporation. Incorporated by reference to Exhibit 3.1 to the
Company’s Form SB-2 filed with the SEC on August 4,
2006. |
3.2 |
|
Certificate
of Amendment to Articles of Incorporation. Incorporated by
reference to the Exhibit 3.1.1 to the Company’s Current Report on
Form 8-K filed with the SEC on December 28, 2007. |
3.3 |
|
Bylaws.
Incorporated by reference to Exhibit 3.2 to the Company’s Form SB-2
filed with the SEC on August 4, 2006. |
4.1 |
|
Specimen
of Common Stock certificate. Incorporated by reference to Exhibit
4.1 to the Company’s Form SB-2 filed with the SEC on August 4,
2006. |
4.2 |
|
Form
of Common Stock Purchase Warrant. Incorporated by reference to
Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with
the SEC on May 4, 2020. |
5.1 |
|
Opinion
of Loeb & Loeb LLP |
23.1 |
|
Consent
of WWC, P.C. Certified Public Accountants |
23.2 |
|
Consent
of Loeb & Loeb LLP (included in Exhibit 5.1) |
24.1 |
|
Power
of Attorney (included in the signature
pages hereto)* |
Item
17. Undertakings.
(a)
The undersigned registrant hereby undertakes:
(1)
To file, during any period in which offers or sales are being made,
a post-effective amendment to this registration
statement:
i. To
include any prospectus required by Section 10(a)(3) of the
Securities Act of 1933;
ii.
To reflect in the prospectus any facts or events arising after the
effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the
aggregate, represent a fundamental change in the information set
forth in the registration statement. Notwithstanding the foregoing,
any increase or decrease in volume of securities offered (if the
total dollar value of securities offered would not exceed that
which was registered) and any deviation from the low or high end of
the estimated maximum offering range may be reflected in the form
of prospectus filed with the Commission pursuant to Rule 424(b) if,
in the aggregate, the changes in volume and price represent no more
than 20 percent change in the maximum aggregate offering price set
forth in the “Calculation of Registration Fee” table in the
effective registration statement.
iii.
To include any material information with respect to the plan of
distribution not previously disclosed in the registration statement
or any material change to such information in the registration
statement.
(2)
That, for the purpose of determining any liability under the
Securities Act of 1933, each such post-effective amendment shall be
deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at
that time shall be deemed to be the initial bona fide
offering thereof.
(3)
To remove from registration by means of a post-effective amendment
any of the securities being registered which remain unsold at the
termination of the offering.
(4)
That for the purpose of determining any liability under the
Securities Act of 1933 in a primary offering of securities of the
undersigned registrant pursuant to this registration statement,
regardless of the underwriting method used to sell the securities
to the purchaser, if the securities are offered or sold to such
purchaser by means of any of the following communications, the
undersigned registrant will be a seller to the purchaser and will
be considered to offer or sell such securities to such
purchaser:
(i)
Any preliminary prospectus or prospectus of the undersigned
registrant relating to the offering required to be filed pursuant
to Rule 424;
(ii)
Any free writing prospectus relating to the offering prepared by or
on behalf of the undersigned registrant or used or referred to by
the undersigned registrant;
(iii)
The portion of any other free writing prospectus relating to the
offering containing material information about the undersigned
registrant or its securities provided by or on behalf of the
undersigned registrant; and
(iv)
Any other communication that is an offer in the offering made by
the undersigned registrant to the purchaser
(b)
The undersigned hereby undertakes to provide to the underwriter at
the closing specified in the underwriting agreements, certificates
in such denominations and registered in such names as required by
the underwriter to permit prompt delivery to each
purchaser.
(c)
Insofar as indemnification for liabilities arising under the
Securities Act of 1933 may be permitted to directors, officers and
controlling persons of the registrant pursuant to the foregoing
provisions, or otherwise, the registrant has been advised that in
the opinion of the Securities and Exchange Commission such
indemnification is against public policy as expressed in the Act
and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by
the registrant of expenses incurred or paid by a director, officer
or controlling person of the registrant in the successful defense
of any action, suit or proceeding) is asserted by such director,
officer or controlling person in connection with the securities
being registered, the registrant will, unless in the opinion of its
counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in
the Act and will be governed by the final adjudication of such
issue.
(d)
The undersigned registrant hereby undertakes that:
(1)
For purposes of determining any liability under the Securities Act
of 1933, the information omitted from the form of prospectus filed
as part of this registration statement in reliance upon Rule 430A
and contained in a form of prospectus filed by the registrant
pursuant to Rule 424(b)(1) or (4) or 497(h) under the
Securities Act shall be deemed to be part of this registration
statement as of the time it was declared effective.
(2)
For the purpose of determining any liability under the Securities
Act of 1933, each post-effective amendment that contains a form of
prospectus shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of
such securities at that time shall be deemed to be the initial bona
fide offering thereof.
SIGNATURES
Pursuant
to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing this Registration Statement on
Form S-3 and has duly caused this Amendment No. 1 to Registration
Statement on Form S-3 to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Baoding
City, Hebei Province, People’s Republic of China, on September 25,
2020.
|
IT TECH PACKAGING,
INC. |
|
|
|
By: |
/s/ Zhenyong Liu |
|
Name: |
Zhenyong Liu |
|
Title: |
Chief Executive Officer
(principal executive officer) |
Pursuant to the requirements of the Securities Act of 1933, this
amendment has been signed by the following persons in the
capacities and on the dates indicated:
Signature |
|
Title |
|
Date |
|
|
|
|
|
/s/
Zhenyong Liu |
|
Chief
Executive Officer and |
|
September
25, 2020 |
Zhenyong
Liu |
|
Chairman
of Board of Directors
(Principal Executive Officer) |
|
|
|
|
|
|
|
/s/
Jing Hao |
|
Chief
Financial Officer |
|
September 25,
2020 |
Jing
Hao |
|
(Principal
Financial and
Accounting Officer) |
|
|
|
|
|
|
|
* |
|
Director |
|
September 25,
2020 |
Marco
Ku Hon Wai |
|
|
|
|
|
|
|
|
|
* |
|
Director |
|
September 25,
2020 |
Wenbing
Christopher Wang |
|
|
|
|
|
|
|
|
|
* |
|
Director |
|
September 25,
2020 |
Fuzeng
Liu |
|
|
|
|
|
|
|
|
|
* |
|
Director |
|
September 25,
2020 |
Lusha
Niu |
|
|
|
|
|
|
|
|
|
*By: |
/s/ Zhenyong Liu |
|
|
|
|
Attorney-in-fact
|
|
|
|
|
II-5